Literature DB >> 17202302

Expression profiling and lung cancer development.

Alain C Borczuk1, Charles A Powell.   

Abstract

Recent lung cancer research has been directed to using molecular approaches to facilitate early diagnosis, to identify clinically relevant biological factors associated with histologic heterogeneity, and to identify novel therapeutic agents. This research takes advantage of technical advances that allow rapid high throughput assays to interrogate the genome, proteome, and epigenome. In this review of gene expression profiling in lung carcinogenesis, we will focus upon recent advances in the understanding of malignant transformation of lung epithelial cells and of lung cancer differentiation and progression. These studies have provided important information about the genomic alterations of tobacco smoke-associated airway field carcinogenesis and about the developmental pathways that mediate lung tumor invasion and histologic differentiation in response to injury.

Entities:  

Mesh:

Year:  2007        PMID: 17202302     DOI: 10.1513/pats.200607-143JG

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  18 in total

Review 1.  Update in lung cancer 2006.

Authors:  Sarita Dubey; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2007-05-01       Impact factor: 21.405

Review 2.  Genomics of lung cancer.

Authors:  Alain C Borczuk; Rebecca L Toonkel; Charles A Powell
Journal:  Proc Am Thorac Soc       Date:  2009-04-15

3.  Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis.

Authors:  James D Bortner; Arunangshu Das; Todd M Umstead; Williard M Freeman; Richard Somiari; Cesar Aliaga; David S Phelps; Karam El-Bayoumy
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

Review 4.  Update in lung cancer 2007.

Authors:  Sarita Dubey; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2008-05-01       Impact factor: 21.405

Review 5.  Do all lung adenocarcinomas follow a stepwise progression?

Authors:  Yasushi Yatabe; Alain C Borczuk; Charles A Powell
Journal:  Lung Cancer       Date:  2011-06-25       Impact factor: 5.705

6.  Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers.

Authors:  Nikolai Daraselia; Yipeng Wang; Adam Budoff; Alexander Lituev; Olga Potapova; Gordon Vansant; Joseph Monforte; Ilya Mazo; Valeria S Ossovskaya
Journal:  Am J Cancer Res       Date:  2011-11-19       Impact factor: 6.166

7.  MicroRNA-30a suppresses non-small-cell lung cancer by targeting Myb-related protein B.

Authors:  Guo-Jun Geng; Ying-Tao Yang; Jie Jiang; Xiu-Yi Yu; Xian-En Fa
Journal:  Exp Ther Med       Date:  2017-11-24       Impact factor: 2.447

Review 8.  Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.

Authors:  Ankit A Desai; Pirro Hysi; Joe G N Garcia
Journal:  Transl Res       Date:  2007-12-18       Impact factor: 7.012

9.  Lung adenocarcinoma invasion in TGFbetaRII-deficient cells is mediated by CCL5/RANTES.

Authors:  A C Borczuk; N Papanikolaou; R L Toonkel; M Sole; L A Gorenstein; M E Ginsburg; J R Sonett; R A Friedman; C A Powell
Journal:  Oncogene       Date:  2007-07-23       Impact factor: 9.867

10.  Genetic variants cis-regulating Xrn2 expression contribute to the risk of spontaneous lung tumor.

Authors:  Y Lu; P Liu; M James; H G Vikis; H Liu; W Wen; A Franklin; M You
Journal:  Oncogene       Date:  2009-11-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.